美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

三倍做多標普生物-Direxion

261.30

-4.7000-1.77%

盤後：261.300.00000.00%19:58 EDT

成交量：22.74萬

成交額：6,097.03萬

市值：4.90億

市盈率：- -

高：278.96

開：273.29

低：261.30

收：266.00

52周最高：341.93

52周最低：74.95

股本：187.45萬

流通股本：187.45萬

量比：0.94

換手率：12.13%

股息：1.00

股息率：0.38%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

中國生物製藥(01177.HK)：LM-364「NECTIN-4TMEADC」臨床試驗申請獲NMPA及FDA批准

美國FDA批准吉利德用於治療艾滋病的口服藥

莫德納獲美國FDA批准，推出2026‑2027版更新新冠疫苗。

美國食品藥品監督管理局：FDA批准首款用於治療成人皮肌炎的口服藥物。

美國 FDA：美敦力召回 2027 年 10 月 20 日前到期的 Bravo CF 相關批次產品。

加拿大皇家銀行首席執行官在電話會議上表示，市場環境總體上仍保持建設性態勢，自然資源、電力基礎設施、戰略防禦、醫療保健及人

醫療健康板塊市場動態綜述

FDA批准首個廣譜RAS抑制劑Rasonque：二線胰腺癌死亡風險降六成，月費3.98萬美元

环球市场播报

人民健康保險銅川分公司被罰9.9萬，涉虛掛中介業務套取費用

福建：擬支持海峽兩岸生物技術和醫療健康產業合作區建設

福建：擬支持海峽兩岸生物技術和醫療健康產業合作區建設

醫療保健板塊市場動態綜述

醫療板塊市場快訊：行業動態與個股分析

FDA 將波士頓科學 Enroute 產品召回劃為最高嚴重等級。

美國食品藥品監督管理局：美國疾病控制與預防中心宣佈與軟質奶酪相關的單核細胞增生李斯特菌疫情已結束，FDA的調查也已完成。

華東醫藥：1類新藥HDM2005獲FDA快速通道資格

江蘇：鼓勵商業健康保險、醫療互助等將創新藥納入保障範圍

江蘇：推進「人工智能+醫療健康」行動

醫療板塊市場快訊：行業動態一覽

石藥創新：控股子公司藥物獲美國FDA快速通道資格

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/LABU/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"三倍做多標普生物-Direxion","latestPrice":261.3,"timestamp":1789156800000,"preClose":266,"halted":0,"volume":227375,"hourTrading":{"tag":"盘后","latestPrice":261.3,"preClose":261.3,"latestTime":"19:58 EDT","volume":728,"amount":191085.6107,"timestamp":1789171090575,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.017669172932330786,"floatShares":1874486,"shares":1874486,"eps":0,"marketStatus":"休市中","change":-4.7,"latestTime":"09-11 16:00:00 EDT","open":273.29,"high":278.9613,"low":261.3,"amount":60970299.293749996,"amplitude":0.066396,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":266,"sharesOutstanding":3074486,"nav":261.603,"aum":516531253.77,"dividendRate":0.003844,"bidAskSpread":0.003144,"preHourTrading":{"tag":"盘前","latestPrice":274.69,"preClose":266,"latestTime":"09:28 EDT","volume":2486,"amount":673283.80262,"timestamp":1789133308224,"change":8.69,"changeRate":0.032669,"amplitude":0.031541},"postHourTrading":{"tag":"盘后","latestPrice":261.3,"preClose":261.3,"latestTime":"19:58 EDT","volume":728,"amount":191085.6107,"timestamp":1789171090575,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9397711565267511,"impliedVol":0.8728,"impliedVolPercentile":0.3227},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1874486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9397711565267511,"shares":1874486,"dividePrice":1.0045,"high":278.9613,"amplitude":0.066396,"preClose":266,"low":261.3,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":261.3,"eps":0,"divideRate":0.003844,"volume":227375,"delay":0,"ttmEps":0,"open":273.29,"prevYearClose":159.39,"prevWeekClose":303.55,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":305.86,"twentyDayClose":273.91,"sixtyDayClose":184.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662689280","title":"中國生物製藥(01177.HK)：LM-364「NECTIN-4TMEADC」臨床試驗申請獲NMPA及FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2662689280","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662689280?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 16:52","pubTimestamp":1787907146,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4585","BK4588","MDTX","PSYK","IBBQ","IBBJ","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662805853","title":"美國FDA批准吉利德用於治療艾滋病的口服藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2662805853","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662805853?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 10:37","pubTimestamp":1787884672,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662080013","title":"莫德納獲美國FDA批准，推出2026‑2027版更新新冠疫苗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662080013","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662080013?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 03:58","pubTimestamp":1787860702,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662803570","title":"美國食品藥品監督管理局：FDA批准首款用於治療成人皮肌炎的口服藥物。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662803570","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662803570?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 03:14","pubTimestamp":1787858068,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662089854","title":"美國 FDA：美敦力召回 2027 年 10 月 20 日前到期的 Bravo CF 相關批次產品。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662089854","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662089854?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 22:59","pubTimestamp":1787842744,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662470717","title":"加拿大皇家銀行首席執行官在電話會議上表示，市場環境總體上仍保持建設性態勢，自然資源、電力基礎設施、戰略防禦、醫療保健及人","url":"https://stock-news.laohu8.com/highlight/detail?id=2662470717","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662470717?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 20:37","pubTimestamp":1787834238,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["VHT","CSIO","BK4130","TRFM","VOLT","TCAI","BK4588","CSEN","JOUL","NOBL","XBI","MGNR","BK4550","BK4596","PWRD","BILT","TEXN","LABU","BLDX","NFRA","TPZ","RIFR","CGVV","BK4585","IPAV","NFRX","XLV","XPAV","FAN","KWH","BILD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197781007","title":"醫療健康板塊市場動態綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1197781007","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197781007?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 16:25","pubTimestamp":1787819101,"startTime":"0","endTime":"0","summary":"此外，诺和诺德的ziltivekimab药物在一项晚期临床试验中未能降低心脏病发作或中风风险后，实际上已退出竞争舞台。这家丹麦制药巨头下月将迎来一场至关重要的资本市场日活动，德意志银行补充道。消息公布后，公司股价下滑1.6%，报300.10丹麦克朗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001127.SGD","LU0235996351.USD","LU0672654166.SGD","LU0675040207.SGD","LU0955648018.USD","LU1839390173.USD","LU0878004406.USD","SG9999001226.SGD","LU0205439572.USD","XLV","SG9999001903.USD","SG9999011175.SGD","SG9999000343.SGD","LU0823417737.USD","SG9999005177.SGD","LU0441854154.USD","SG9999016042.SGD","LU2506952097.USD","LU0588545904.SGD","SG9999002604.SGD","SG9999013486.USD","LU1956131251.USD","LU0326948709.USD","IE00BVYPNP33.GBP","LU2238330802.EUR","LU0823397103.USD","LU2506951875.HKD","SG9999002620.SGD","SG9999014484.SGD","IE0003895053.USD","SG9999003800.SGD","LU1497733557.USD","SG9999013353.USD","LU0557290698.USD","LU2152927971.USD","LU2506952170.USD","SG9999001135.SGD","XBI","IE00BGHQDM52.EUR","LU0210637038.USD","BK6112","LU0971096721.USD","LU0543330483.HKD","LU0823038988.USD","SG9999013478.USD","LU1211504680.USD","LU0169518387.USD","LU0261945553.USD","SGXZ24219693.SGD","LU0648948544.HKD","LU0061477393.USD","SG9999002414.USD","SG9999014492.USD","SGXZ43160589.SGD","SGXZ16066938.SGD","LU0345776255.USD","LU0251143029.SGD","LU0823413660.USD","LU1363072403.SGD","LU0084288322.USD","LU0955623706.USD","LU0823397285.USD","LU0384037296.USD","LU1634259557.SGD","IE00BKZH1Z71.USD","LU0577902611.USD","LU0043850808.USD","LU2257852520.SGD","SG9999004360.SGD","SG9999006266.SGD","SG9999008742.SGD","SGXZ70427877.SGD","LU0165289439.USD","LU0188438112.USD","LU1634259391.SGD","SG9999002562.SGD","LU0577902371.SGD","SG9999013460.SGD","LU0488056044.USD","SG9999000459.SGD","BK4581","LU0577902454.USD","SG9999009443.AUD","BK6516","LU0011963245.USD","LU0762540952.USD","LU0441851309.USD","LU1497733631.SGD","LU0048597586.USD","SGXZ27511609.SGD","LU0831093199.SGD","LU2237957811.SGD","LU1282649067.USD","LU0950375773.USD","SG9999014302.SGD","LU0211331839.USD","LU0048573645.USD","LU0251144936.SGD","SG9999000475.SGD","LU1497734951.SGD","LU0873338254.USD","LU0831103253.SGD","LU0588545490.SGD","SG9999007991.SGD","SG9999002406.SGD","LU0532188223.SGD","LU1282649141.HKD","BK6523","LU2237957902.USD","LU0128522157.USD","BK4585","LU0345775950.USD","SG9999001846.SGD","LU1504937902.USD","SG9999002679.SGD","SGXZ91733576.SGD","LU0315178854.USD","IE00BVYPNQ40.USD","LU0882747503.HKD","LABU","BK4588","LU0823417653.USD","IE0031814969.USD","LU2506951958.HKD","SG9999003826.SGD","LU1770036033.HKD","LU0955669360.SGD","LU0096374516.USD","LU0630378429.USD","LU1130305938.SGD","LU0737861269.HKD","D05.SI","LU3227948356.SGD","LU0588545730.USD","SGXZ58947870.SGD","LU0577902298.EUR","LU1522347837.USD","LU0823039010.USD","LU1282649810.SGD","LU0823413587.USD","LU0865486749.SGD","LU0878005551.USD","SG9999003925.USD","LU0192582467.USD","LU0261947096.USD","LU0577902538.SGD","LU0320764755.SGD","LU0886674414.USD","LU0029875118.USD","SGXZ51708014.SGD","SG9999004220.SGD","LU0898667661.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662249779","title":"FDA批准首個廣譜RAS抑制劑Rasonque：二線胰腺癌死亡風險降六成，月費3.98萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662249779","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662249779?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 15:55","pubTimestamp":1787817300,"startTime":"0","endTime":"0","summary":"当地时间8月26日，美国食品药品管理局批准Revolution Medicines公司的口服药Rasonque，用于已接受至少一线全身治疗、或不适合多药联合全身治疗的成年转移性胰腺腺癌患者。这是该适应证下首个获批的广谱RAS抑制剂。批发采购成本为每30天39800美元。公司称RAS G12突变人群方向一致。同管道的另一款RAS抑制剂zoldonrasib已在6月进入与化疗联合用于RAS G12D转移性胰腺癌一线的III期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-27/doc-iniptxkt5340944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662775745","title":"人民健康保險銅川分公司被罰9.9萬，涉虛掛中介業務套取費用","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775745","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775745?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:56","pubTimestamp":1787813815,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月27日讯，近日，铜川金融监管分局发布行政处罚决定书，剑指中国人民健康保险股份有限公司铜川分公司及相关责任人。罚单显示，中国人民健康保险股份有限公司铜川分公司的主要违法违规行为是：利用保险代理人虚挂中介业务套取费用。针对上述违法行为，铜川金融监管分局对中国人民健康保险股份有限公司铜川分公司罚款9.9万元；对宋鹏飞给予警告并处罚款1.1万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787810487255386596","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["XBI","BK4585","BK4581","XLV","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662775292","title":"福建：擬支持海峽兩岸生物技術和醫療健康產業合作區建設","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775292","media":"格隆汇APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775292?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:49","pubTimestamp":1787813340,"startTime":"0","endTime":"0","summary":"格隆汇8月27日丨今日，《福建省“十五五”卫生健康发展规划》印发。其中提到，深化卫生健康两岸融合发展，构建跨区域开放发展新格局。加强两岸医疗健康产业合作，推动闽台在生物医药研发、重大疾病防控、前沿医疗技术研究等领域交流合作。支持海峡两岸生物技术和医疗健康产业合作区建设。深化闽台医药融合，鼓励引进台湾地区已上市的高临床价值创新药械在本省医疗机构应用。支持福建中医药大学建设闽台融合中医药重点实验室。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2026-08-27/doc-inipttav9117970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HELX","WDNA","VHT","XBI","LABU","BK4585","159760","BK4550","BK4588","BK4581","IXJ","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662077593","title":"福建：擬支持海峽兩岸生物技術和醫療健康產業合作區建設","url":"https://stock-news.laohu8.com/highlight/detail?id=2662077593","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662077593?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:45","pubTimestamp":1787813117,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","BK4588","LABU","VHT","BK4581","WDNA","BK4585","HELX","IXJ","BK4550","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171038950","title":"醫療保健板塊市場動態綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1171038950","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171038950?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 04:53","pubTimestamp":1787777585,"startTime":"0","endTime":"0","summary":"医疗保健领域最新市场快讯，涵盖了多家重要企业的动态与分析师观点。伯恩斯坦研究指出，依视路陆逊梯卡旗下核心品牌雷朋可能因其智能眼镜产品线引发的隐私担忧而遭受长期声誉损害。杰富瑞分析师在一份研究报告中表示，基础医疗控股的长期增长轨迹受到医疗保健使用率上升及其他利好因素的支撑。其门诊设施使其能够从医院护理向门诊护理转移的趋势中获益。杰富瑞首次覆盖该股，给予买入评级，目标价为1.10新加坡元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4581","XBI","XLV","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175698162","title":"醫療板塊市場快訊：行業動態與個股分析","url":"https://stock-news.laohu8.com/highlight/detail?id=1175698162","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175698162?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 00:24","pubTimestamp":1787761489,"startTime":"0","endTime":"0","summary":"医疗健康板块最新市场快讯，涵盖多家重点企业动态与投资机构观点。0343 ET - 花旗研究维持对药明合联的看涨立场，基于该公司上半年业绩所展现的强劲增长可见性。该股下跌3.6%，报77.30港元。分析师指出，市场热烈反应可能表明部分交易者误将该疫苗理解为预防性治疗，而Moderna可能要到2030年才能实现盈利。Moderna股价上涨14%至158.10美元，过去一个月内市值已近乎翻两番。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4581","XBI","XLV","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748507","title":"FDA 將波士頓科學 Enroute 產品召回劃為最高嚴重等級。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748507","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662748507?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 22:58","pubTimestamp":1787756280,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2506951875.HKD","LABU","LU0882574055.USD","LU1720051017.SGD","SG9999001176.USD","LU0528227936.USD","IE00BJT1NW94.SGD","LU2242649171.HKD","LU1720051108.HKD","LU0187121727.USD","LU2087625088.SGD","LU2491050071.SGD","LU2362540622.SGD","SG9999001176.SGD","BK4581","LU2362541513.USD","LU0138981039.USD","LU1989764748.USD","LU2244417387.USD","IE00BJJMRZ35.SGD","LU2324357040.USD","BK4082","IE0002141913.USD","LU0238689110.USD","IE00B2B36J28.USD","LU1989772923.USD","LU2506952170.USD","BK4504","LU0823417737.USD","LU1548497426.USD","LU0048584097.USD","BSX","LU0266013472.USD","LU0267386448.USD","LU1989772840.SGD","LU0432979614.USD","LU0011850046.USD","LU1366192091.USD","LU0823416689.USD","LU0345769128.USD","LU1153585028.USD","LU1791710400.SGD","LU0114720955.EUR","LU2357305700.SGD","LU0823417653.USD","LU0122379950.USD","SGXZ57979304.SGD","BK4588","LU0077335932.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662710487","title":"美國食品藥品監督管理局：美國疾病控制與預防中心宣佈與軟質奶酪相關的單核細胞增生李斯特菌疫情已結束，FDA的調查也已完成。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662710487","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662710487?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 22:33","pubTimestamp":1787754831,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662731719","title":"華東醫藥：1類新藥HDM2005獲FDA快速通道資格","url":"https://stock-news.laohu8.com/highlight/detail?id=2662731719","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662731719?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 20:24","pubTimestamp":1787747041,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662973237","title":"江蘇：鼓勵商業健康保險、醫療互助等將創新藥納入保障範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=2662973237","media":"金融一线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662973237?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 18:05","pubTimestamp":1787738700,"startTime":"0","endTime":"0","summary":"8月26日金融一线消息，江苏省印发《江苏省促进生物医药产业高质量发展三年行动计划》。其中提到，健全完善多元支付体系。鼓励商业健康保险、医疗互助等将创新药纳入保障范围，做优做强“江苏医惠保”等惠民商业健康保险。医保部门依托医保行业可信数据空间，对符合条件的商业健康保险给予数据融合应用、结算清分等方面的合作，相关商业健康保险保障范围内的创新药应用病例可不纳入按病种付费范围，经审核评议程序后支付。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jryx/insurance/2026-08-26/doc-iniprumn0944717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","BK4585","BK4588","LNGR","159992","BK1574","IBBQ","BK1161","06978","BK4581","XLV","159891","MEDX","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662944767","title":"江蘇：推進「人工智能+醫療健康」行動","url":"https://stock-news.laohu8.com/highlight/detail?id=2662944767","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662944767?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 17:42","pubTimestamp":1787737348,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NJAN","ARTY","PBOT","TQQY","QQQX","QQQ","DQJN","AGIX","AIBU","MFIG","QSWN","03034","PSQ","QQQM","TQQQ","KOMP","QDEC","GPIQ","TARK","NBDS","NOCT","AIFD","QID","VUSE","02834","IXJ","NEWZ","NAPR","VHT","GK","WPAI","CWC","QLD","AQGX","NJUL","XLV","CPNQ","MVPS","TECY","CHAT","QTOC","SQQQ","QMAR","LCLG","OGIG","AIQU","FWD","XBI","QQA","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159893233","title":"醫療板塊市場快訊：行業動態一覽","url":"https://stock-news.laohu8.com/highlight/detail?id=1159893233","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159893233?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 16:25","pubTimestamp":1787732717,"startTime":"0","endTime":"0","summary":"0743 GMT——花旗研究在药明合联公布上半年业绩后，基于其强劲的增长可见性，继续维持对该股的看涨立场。分析师指出，这家医疗保健服务公司的管理层重申了2026年指引，预计2025年至2030年间收入复合年增长率将达30%-35%，同时提及包括里程碑费用在内的总积压订单同比增长了62%。该行将目标价由此前的73.00港元上调至93.00港元，并维持买入评级。该股目前下跌3.6%，报77.30港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","XLV","BK4585","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662956217","title":"石藥創新：控股子公司藥物獲美國FDA快速通道資格","url":"https://stock-news.laohu8.com/highlight/detail?id=2662956217","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662956217?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 16:00","pubTimestamp":1787731255,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}